| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/03/2008 | CA2672715A1 Antibodies against insulin-like growth factor i receptor and uses thereof |
| 07/03/2008 | CA2672639A1 Indol-4-yl-pyrimidinyl-2-yl-amine derivatives and use thereof as cyclin dependant kinase inhibitors |
| 07/03/2008 | CA2672518A1 Organic compounds and their uses |
| 07/03/2008 | CA2672438A1 Substituted heterocycles and methods of use |
| 07/03/2008 | CA2672213A1 New compounds |
| 07/03/2008 | CA2672172A1 Bicyclic heterocyclic compounds as fgfr inhibitors |
| 07/03/2008 | CA2672155A1 Use of xanthohumol or isoxanthohumol as an active substance for the prevention and/or control of liver diseases |
| 07/02/2008 | EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene |
| 07/02/2008 | EP1939290A2 Gene expression control |
| 07/02/2008 | EP1939278A1 Method for production of t cell population |
| 07/02/2008 | EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 07/02/2008 | EP1939202A1 Novel adenine compound |
| 07/02/2008 | EP1939201A1 Novel adenine compound |
| 07/02/2008 | EP1939200A1 Novel adenine compound |
| 07/02/2008 | EP1939199A1 Novel adenine compound |
| 07/02/2008 | EP1939198A1 Novel adenine compound |
| 07/02/2008 | EP1939195A1 New indole derivatives and their use as medicine |
| 07/02/2008 | EP1939188A1 Oxa-and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 07/02/2008 | EP1939186A1 5-Fluorouracil derivatives and their use for the treatment of cancer |
| 07/02/2008 | EP1939185A1 New types of hetaryl-phenylendiamin-pyrimidines as protein kinase inhibitors for the treatment of cancer |
| 07/02/2008 | EP1938828A1 Use of lupulones for the prevention and treatment of colorectal cancer |
| 07/02/2008 | EP1938827A1 Novel inhibitor of vascular endothelial growth factor expression |
| 07/02/2008 | EP1938823A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 07/02/2008 | EP1938821A2 Methods of administering epothilone analogs for the treatment of cancer |
| 07/02/2008 | EP1938819A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938818A2 Use of specific cyclolignans |
| 07/02/2008 | EP1938816A2 Compounds and methods for inducing apoptosis in cancer cells |
| 07/02/2008 | EP1938798A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 07/02/2008 | EP1938699A1 Extract liquid containing -cryptoxanthin ingredient, and food or beverage and soap or cosmetic each containing the extract liquid |
| 07/02/2008 | EP1937815A1 Methods and compositions for modulating tumor cell activity |
| 07/02/2008 | EP1937814A2 Anti-apoptotic protein antibodies |
| 07/02/2008 | EP1937710A1 Kinin b1 receptor peptide agonists and uses thereof |
| 07/02/2008 | EP1937682A1 Met kinase inhibitors |
| 07/02/2008 | EP1937681A1 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of c-fms kinase |
| 07/02/2008 | EP1937671A2 Benzimidazole thiophene compounds as plk inhibitors |
| 07/02/2008 | EP1937668A1 Octahydropentalene-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 07/02/2008 | EP1937667A2 Benzimidazoles useful as inhibitors of protein kinases |
| 07/02/2008 | EP1937665A1 4- (4-BROMO-2-FLUOROANILINO) -6-METHOXY-7- (l-METHYLPIPERIDIN-4 -YLMETHOXY) QUINAZOLINE MONOHYDRATE |
| 07/02/2008 | EP1937650A1 Heterocyclic compounds |
| 07/02/2008 | EP1937644A1 Novel ansamycin derivatives |
| 07/02/2008 | EP1937310A2 Use of conjugates of doxorubicin with lactosaminated albumin |
| 07/02/2008 | EP1937288A2 Carotenoid oxidation products as chemopreventive and chemotherapeutic agents |
| 07/02/2008 | EP1937279A2 Use of inhibitors of pi3k-c2a for the treatment of apoptosis-related disorders |
| 07/02/2008 | EP1937277A1 Method of acting upon organism by targeted delivery of biologicaly active substances into m itochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose |
| 07/02/2008 | EP1937268A2 Indenoisoquinolinone analogs and methods of use thereof |
| 07/02/2008 | EP1937251A2 Pharmaceutical compositions and methods comprising a combination of a selective estrogen receptor modulator and an aromatase inhibitor |
| 07/02/2008 | EP1694845A4 Anticarcinoma antibidies and uses thereof |
| 07/02/2008 | EP1660100B1 Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents |
| 07/02/2008 | EP1474425B9 Deazapurines and uses thereof |
| 07/02/2008 | EP1459762B1 Use of emp9 for the prevention of proliferative organ diseases |
| 07/02/2008 | EP1171468B1 Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2-scFv Fragment |
| 07/02/2008 | EP1169347B1 Compounds and methods for therapy and diagnosis of lung cancer |
| 07/02/2008 | EP1141003B9 Methods of activation of SGK by phosphorylation. |
| 07/02/2008 | EP1115720B1 Novel n-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
| 07/02/2008 | EP0896055B1 Apoptosis inducing protein and gene encoding the same |
| 07/02/2008 | EP0667912B1 Defective adenovirus vectors and use thereof in gene therapy |
| 07/02/2008 | CN101213196A Derivatives of pyrido[2,3-d]pyrimidine, the preparation thereof, and the therapeutic application of the same |
| 07/02/2008 | CN101213195A Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect |
| 07/02/2008 | CN101213192A Pyrimidine-substituted benzimidazole derivatives as protein kinase inhibitors |
| 07/02/2008 | CN101213186A Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents |
| 07/02/2008 | CN101213179A 2,4-diamino-pyrimidines used as Aurora inhibitors |
| 07/02/2008 | CN101213178A Benzenoid ansamycin derivative |
| 07/02/2008 | CN101212982A FK228 derivates as HDAC inhibitors |
| 07/02/2008 | CN101212980A Use of macrolides for treating intestinal inflammation |
| 07/02/2008 | CN101212961A HMB compositions and uses thereof |
| 07/02/2008 | CN101210244A Neutrokine-alpha and Neutrokine-alpha splice variants |
| 07/02/2008 | CN101210051A Anti-VEGF antibodies |
| 07/02/2008 | CN101210050A Anti-vegf antibodies |
| 07/02/2008 | CN101210048A Anti-CD33 engineering antibody for target conjugated marrow series leukemia cell and its expression vector and use |
| 07/02/2008 | CN101210037A Short interference ribonucleic acid pointed to human OPN gene for treating tumor gene |
| 07/02/2008 | CN101210018A Method for preparing deguelin |
| 07/02/2008 | CN101210012A Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 07/02/2008 | CN101209350A Polyglutamate-medicament coupling compound with amino acid as communicating terminal |
| 07/02/2008 | CN101209349A Application of carbon nano-tube as carrier in transferring anti-cancer medicine |
| 07/02/2008 | CN101209348A Elastic nano vesicle carrier and preparation and application thereof |
| 07/02/2008 | CN101209334A Lung cancer-treating medicament and preparation thereof |
| 07/02/2008 | CN101209264A Total toadpoison lactones extraction with anti-tumor function, preparation and application thereof |
| 07/02/2008 | CN101209263A Medicine for treating tumor |
| 07/02/2008 | CN101209256A Polydatin medicinal composition containing polyvinyl pyrrolidone |
| 07/02/2008 | CN101209251A Elastic nano vesicle preparations containing paclitaxel or docetaxel and preparation thereof |
| 07/02/2008 | CN101209248A Preparation of tamoxifen citrate microcapsule prepared by complex coacervation method |
| 07/02/2008 | CN101209247A Preparation of colon-targeted preparation |
| 07/02/2008 | CN101209243A Liposome medicament and preparation thereof |
| 07/02/2008 | CN100398649C Human leukemia related reverse transcript virus gene genome nucleic acid sequence and its application |
| 07/02/2008 | CN100398558C Active segment of HER2/neu with Herstatin interaction, coding gene and application thereof |
| 07/02/2008 | CN100398557C Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 07/02/2008 | CN100398550C Process for synthesis of oxaliplatin as anticancer medicine |
| 07/02/2008 | CN100398541C Pyrimidinone derivatives and 3-keto ester |
| 07/02/2008 | CN100398540C Aryl heterocyclic imidazole naphthaimide kind compound and its application |
| 07/02/2008 | CN100398521C 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase MMP12 |
| 07/02/2008 | CN100398520C Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer |
| 07/02/2008 | CN100398137C Compound traditional Chinese medicine for treating fibroid and muller-iosis and its preparation method |
| 07/02/2008 | CN100398113C Nano selenium of Melatonin and its preparation method |
| 07/01/2008 | USRE40418 Treatment of neoplasms with CCI-779/EKB-569 combination |
| 07/01/2008 | US7395112 Method and apparatus for treating tumors using low strength electric fields |
| 07/01/2008 | US7393953 Polymeric acyl derivatives of indoles |
| 07/01/2008 | US7393951 antisense to a nucleotide sequence of positions 47 to 51 of 7SL RNA of the signal recognition particle (SRP); inhibitor of cancer cell growth |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393932 Endothelial cell expression patterns |
| 07/01/2008 | US7393870 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |